Expression Analysis of caspase-6,caspase-9 and BNIP3 in Prostate Cancer

Danial N.N. , Korsmeyer S.J. : Cell death: critical control points. Cell, 116: 205–219, 2004.

Reed J.C. : Mechanisms of apoptosis. Am J Pathol, 39: 1415–1430, 2000.

Hanahan D. , Weinberg R.A. : The hallmarks of cancer. Cell, 100: 57–70, 2000.

Vande Velde C. , Cizeau J. , Dubik D. , Alimonti J. , Brown T. , Israels S. , Hakem R. , Greenberg A.H. : BNIP3 and genetic control of necrosis-like cell death through the mitochondrial permeability transition pore. Mol Cell Biol, 20: 5454–5468, 2000.

Sowter H.M. , Ratcliffe P.J. , Watson P. , Greenberg A.H. , Harris A.L. : HIF-1-dependent regulation of hypoxic induction of the cell death factors BNIP3 and NIX in human tumors. Cancer Res, 61: 6669–6673, 2001.

Lee S.H. , Shin M.S. , Park W.S. , Kim S.Y. , Kim H.S. , Han J.Y. , Park G.S. , Dong S.M. , Pi J.H. , Kim C.S. , Kim S.H. , Lee J.Y. , Yoo N.J. : Alterations of Fas (Apo-1/CD95) gene in non-small cell lung cancer. Oncogene, 18: 3754–3760, 1999.

Kim H.S. , Lee J.W. , Soung Y.H. , Park W.S. , Kim S.Y. , Lee J.H. , Park J.Y. , Cho Y.G. , Kim C.J. , Jeong S.W. , Nam S.W. , Kim S.H. , Lee J.Y. , Yoo N.J. , Lee S.H. : Inactivating mutations of caspase-8 gene in colorectal carcinomas. Gastroenterology, 125: 708–715, 2003.

Soung Y.H. , Lee J.W. , Kim S.Y. , Jang J. , Park Y.G. , Park W.S. , Nam S.W. , Lee J.Y. , Yoo N.J. , Lee S.H. : CASPASE-8 gene is inactivated by somatic mutations in gastric carcinomas. Cancer Res, 65: 815–821, 2005.

Soung Y.H. , Lee J.W. , Kim H.S. , Park W.S. , Kim S.Y. , Lee J.H. , Park J.Y. , Cho Y.G. , Kim C.J. , Park Y.G. , Nam S.W. , Jeong S.W. , Kim S.H. , Lee J.Y. , Yoo N.J. , Lee S.H. : Inactivating mutations of CASPASE-7 gene in human cancers. Oncogene, 22: 8048–8052, 2003.

Yoo N.J. , Lee J.W. , Kim Y.J. , Soung Y.H. , Kim S.Y. , Nam S.W. , Park W.S. , Lee J.Y. , Lee S.H. : Loss of caspase-2, −6 and −7 expression in gastric cancers. APMIS, 112: 330–335, 2004.

Yoo N.J. , Kim H.S. , Kim S.Y. , Park W.S. , Kim S.H. , Lee J.Y. , Lee S.H. : Stomach cancer highly expresses both initiator and effector caspases; an immunohistochemical study. APMIS, 110: 825–832, 2002.

Kim S.Y. , Song S.Y. , Kim M.S. , Lee J.Y. , Lee H.M. , Choi H.Y. , Yoo N.J. , Lee S.H. : Immunohistochemical analysis of Fas and FLIP in prostate cancers. APMIS, 117: 28–33, 2009.

Lee S.H. , Jeong E.G. , Yoo N.J. , Lee S.H. : Mutational and expressional analysis of BNIP3, a pro-apoptotic Bcl-2 member, in gastric carcinomas. APMIS, 115: 1274–1280, 2007.

Zhang X. , Jin T.G. , Yang H. , DeWolf W.C. , Khosravi-Far R. , Olumi A.F. : Persistent c-FLIP(L) expression is necessary and sufficient to maintain resistance to tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in prostate cancer. Cancer Res, 64: 7086–7091, 2004.

Jiang J. , Ulbright T.M. , Zhang S. , Eckert G.J. , Kao C. , Gardner T.A. , Koch M.O. , Eble J.N. , Cheng L. Fas and Fas ligand expression is elevated in prostatic intraepithelial neoplasia and prostatic adenocarcinoma. Cancer, 95: 296–300, 2002.

Suzuki A. , Matsuzawa A. , Iguchi T. : Down regulation of Bcl-2 is the first step on Fas-mediated apoptosis of male reproductive tract. Oncogene, 13: 31–37, 1996.

Santourlidis S. , Warskulat U. , Florl A.R. , Maas S. , Pulte T. , Fischer J. , Müller W. , Schulz W.A. : Hypermethylation of the tumor necrosis factor receptor superfamily 6 (APT1, Fas, CD95/Apo-1) gene promoter at rel/nuclear factor kappaB sites in prostatic carcinoma. Mol Carcinog, 32: 36–43, 2001.

O'Kane H.F. , Watson C.J. , Johnston S.R. , Petak I. , Watson R.W. , Williamson K.E. : Targeting death receptors in bladder, prostate and renal cancer. J Urol, 175: 432–438, 2006.

Kononen J. , Bubendorf L. , Kallioniemi A. , Barlund M. , Schraml P. , Leighton S. , Torhorst J. , Mihatsch M.J. , Sauter G. , Kallioniemi O.P. : Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med, 4: 844–847, 1998.

Palmerini F. , Devilard E. , Jarry A. , Birg F. , Xerri L. : Caspase 7 downregulation as an immunohistochemical marker of colonic carcinoma. Hum Pathol, 32: 461–467, 2001.

Winter R.N. , Kramer A. , Borkowski A. , Kyprianou N. : Loss of caspase-1 and caspase-3 protein expression in human prostate cancer. Cancer Res, 61: 1227–1232, 2001.

Joseph B. , Ekedahl J. , Sirzen F. , Lewensohn R. , Zhivotovsky B. : Differences in expression of pro-caspases in small cell and non-small cell lung carcinoma. Biochem Biophys Res Commun, 262: 381–387, 1999.

Takayama H. , Takakuwa T. , Dong Z. , Nonomura N. , Okuyama A. , Nagata S. , Aozasa K. : Fas gene mutations in prostatic intraepithelial neoplasia and concurrent carcinoma: analysis of laser capture microdissected specimens. Lab Invest, 81: 283–828, 2001.